Review: could Norvasc cause Skin Discoloration - Bluish?


Summary

Skin discoloration - bluish is found among people who take Norvasc, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Coumadin, and have Hypertension . We study 97,463 people who have side effects while taking Norvasc from FDA and social media. Among them, 108 have Skin discoloration - bluish. Find out below who they are, when they have Skin discoloration - bluish and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Norvasc

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. (latest outcomes from Norvasc 99,486 users)

Skin Discoloration - Bluish

Skin discoloration - bluish (bluish colour of skin) has been reported by people with weight decreased, swallowing difficulty, bone marrow toxicity, progressive multifocal leukoencephalopathy, pneumonia (latest reports from 10,988 Skin discoloration - bluish patients).

On Sep, 18, 2016

97,463 people reported to have side effects when taking Norvasc.
Among them, 108 people (0.11%) have Skin Discoloration - Bluish


Number of reports submitted per year:

Could Norvasc cause Skin discoloration - bluish?

Time on Norvasc when people have Skin Discoloration - Bluish *:

  • < 1 month: 37.5 %
  • 1 - 6 months: 37.5 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 25.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Skin Discoloration - Bluish when taking Norvasc *:

  • female: 48.6 %
  • male: 51.4 %

Age of people who have Skin Discoloration - Bluish when taking Norvasc *:

  • 0-1: 1.04 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.08 %
  • 30-39: 2.08 %
  • 40-49: 5.21 %
  • 50-59: 17.71 %
  • 60+: 71.88 %

Severity if Skin Discoloration - Bluish when taking Norvasc **:

  • least: 0.0 %
  • moderate: 100 %
  • severe: 0.0 %
  • most severe: 0.0 %

How people recovered from Skin Discoloration - Bluish **:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Top conditions involved for these people *:

  • Hypertension (21 people, 19.44%)
  • Pain (6 people, 5.56%)
  • Osteoporosis (4 people, 3.70%)
  • Metastatic Renal Cell Carcinoma (4 people, 3.70%)
  • Ill-Defined Disorder (4 people, 3.70%)

Top co-used drugs for these people *:

  • Coumadin (20 people, 18.52%)
  • Zofran (15 people, 13.89%)
  • Protonix (15 people, 13.89%)
  • Lasix (15 people, 13.89%)
  • Oxycontin (14 people, 12.96%)

Top other side effects for these people *:

  • Dyspnoea (41 people, 37.96%)
  • Anxiety (23 people, 21.30%)
  • Vomiting (22 people, 20.37%)
  • Pain (21 people, 19.44%)
  • Dizziness (21 people, 19.44%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Skin discoloration - bluish when taking Norvasc?

Browse all side effects of Norvasc

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Skin discoloration - bluish

Skin discoloration - bluish

Could your condition cause Skin discoloration - bluish

Skin discoloration - bluish

Related studies

Can you answer these questions?

More questions for: Norvasc, Skin discoloration - bluish

You may be interested in these reviews

More reviews for: Norvasc, Skin discoloration - bluish


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.